Corrigendum to "Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients" [Prog Neuro-Psychopharmacol Biol Psychiatry 51 (2014) 190-195]http://dx.doi.org/10.1016/j.pnpbp.2014.02.006.;Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 51, Issue , 2014, Pages 190-195

  Spellmann, Ilja ^a   Rujescu, Dan ^b   Musil, Richard ^a   Giegling, Ina ^b   Genius, Just ^c   Zill, Peter ^a   Dehning, Sandra ^a   Cerovecki, Anja ^a   Seemüller, Florian ^a   Schennach, Rebecca ^a   Hartmann, Annette M ^a   Schäfer, Martin ^a   Müller, Norbert ^a   Möller, Hans Jürgen ^a   Riedel, Michael ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Antipsychotics; Intracellular signaling; Pharmacogenetics; Pleckstrin homology domain; Schizophrenia; Therapy response

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; HOMEODOMAIN PROTEIN; PLEKHA6 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG RESPONSE; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MONOTHERAPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PLECKSTRIN HOMOLOGY DOMAIN CONTAINING 6 GENE; POSITIVE AND NEGATIVE SYNDROME SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LONG EVANS RAT; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RAT; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HALOPERIDOL; HOMEODOMAIN PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RATS; RATS, LONG-EVANS; SCHIZOPHRENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896056673     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.11.007     Document Type: Erratum

References (30)

1. Akaike A new look at the statistical model identification. System identification and time-series analysis. IEEE Trans Automatic Control 1974, AC-19:716-723.
2. Arnsten A.F. Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness. Cereb Cortex 2007, 17(Suppl. 1):i6-i15.
3. Braun I., Genius J., Grunze H., Bender A., Möller H.J., Rujescu D. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr Res 2007, 97:254-263.
4. Cepeda C., Andre V.M., Jocoy E.L. Levine MS. NMDA and dopamine: diverse mechanisms applied to interacting receptor systems 2009.
5. Craddock N., O'Donovan M.C., Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006, 32:9-16.
6. Genius J., Geiger J., Dölzer A.L., Benninghoff J., Giegling I., Hartmann A.M., Möller H.J., Rujescu D. Glutamatergic dysbalance and oxidative stress in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism. PLoS One 2013, 8:e59395.
7. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005, 10:40-68. [image 5].
8. Hirvonen J., Hietala J. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems. CNS Neurosci Ther 2011, 17:89-96.
9. Horacek J., Bubenikova-Valesova V., Kopecek M., Palenicek T., Dockery C., Mohr P., et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 2006, 20:389-409.
10. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
11. Keshavan M.S., Morris D.W., Sweeney J.A., Pearlson G., Thaker G., Seidman L.J., et al. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr Res 2011, 133:250-254.
12. Kornhuber J., Schultz A., Wiltfang J., Meineke I., Gleiter C.H., Zochling R., et al. Persistence of haloperidol in human brain tissue. Am J Psychiatry 1999, 156:885-890.
13. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
14. Lemmon M.A. Pleckstrin homology (PH) domains and phosphoinositides. Biochem Soc Symp 2007, 81-93.
15. Lemmon M.A., Ferguson K.M., Abrams C.S. Pleckstrin homology domains and the cytoskeleton. FEBS Lett 2002, 513:71-76.
16. Lesch K.P., Selch S., Renner T.J., Jacob C., Nguyen T.T., Hahn T., et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry 2011, 16:491-503.
17. Leucht S., Busch R., Hamann J., Kissling W., Kane J.M. Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended. Biol Psychiatry 2005, 57:1543-1549.
18. MacDonald J.F., Jackson M.F., Beazely M.A. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors. Crit Rev Neurobiol 2006, 18:71-84.
19. Molteni R., Calabrese F., Racagni G., Fumagalli F., Riva M.A. Antipsychotic drug actions on gene modulation and signaling mechanisms. Pharmacol Ther 2009, 124:74-85.
20. Muller N., Schwarz M. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 2006, 10:131-148.
21. Rapoport J.L., Addington A.M., Frangou S., Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 2005, 10:434-449.
22. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., Giegling I., Genius J., McCarley R.W., Möller H.J., Grunze H. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 2006, 59:721-729.
23. Spellmann I., Rujescu D., Musil R., Mayr A., Giegling I., Genius J., et al. Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients. J Psychiatr Res 2011, 45:234-241.
24. Stahl S.M. Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. CNS Spectr 2007, 12:265-268.
25. Team RDC A language and environment for statistical computing 2008, Foundation for Statistical Computing, Vienna, Austria, [URL http://www.R-project.org].
26. van Rossum D.B., Patterson R.L., Sharma S., Barrow R.K., Kornberg M., Gill D.L., et al. Phospholipase Cgamma1 controls surface expression of TRPC3 through an intermolecular PH domain. Nature 2005, 434:99-104.
27. Wang D.S., Shaw G. The association of the C-terminal region of beta I sigma II spectrin to brain membranes is mediated by a PH domain, does not require membrane proteins, and coincides with a inositol-1,4,5 triphosphate binding site. Biochem Biophys Res Commun 1995, 217:608-615.
28. Wang D.S., Shaw R., Winkelmann J.C., Shaw G. Binding of PH domains of beta-adrenergic receptor kinase and beta-spectrin to WD40/beta-transducin repeat containing regions of the beta-subunit of trimeric G-proteins. Biochem Biophys Res Commun 1994, 203:29-35.
29. Xu Q., Bateman A., Finn R.D., Abdubek P., Astakhova T., Axelrod H.L., et al. Bacterial pleckstrin homology domains: a prokaryotic origin for the PH domain. J Mol Biol 2010, 396:31-46.
30. Yao L., Kawakami Y., Kawakami T. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci U S A 1994, 91:9175-9179.